Description

Erbisol Vials 2 ml, #10 Solution

Composition

Each 2 ml vial of Erbisol contains a proprietary blend of biologically active low-molecular weight compounds derived from natural sources. While the exact formulation is confidential, it is standardized to include compounds with immunomodulatory, anti-inflammatory, and hepatoprotective activity.

Active Ingredient

The primary active substances in Erbisol include amino acids, peptides, nucleotides, and polyunsaturated fatty acids. These components are believed to exert regulatory effects on immune system functioning and tissue repair processes.

Excipients

Excipients in Erbisol include water for injection and pH-stabilizing agents. All excipients are non-toxic and pharmacologically inactive, selected to ensure stability and sterility of the solution.

Indications

• Chronic viral hepatitis (as adjunctive therapy)
• Autoimmune diseases (under medical supervision)
• Chronic inflammatory conditions
• Supportive treatment in chemotherapy and radiotherapy to reduce toxicity
• Diabetic complications, such as diabetic retinopathy and nephropathy

Contraindications

• Hypersensitivity to any component of Erbisol
• Pregnancy and breastfeeding (unless specifically prescribed)
• Children under 18 years of age (safety data is limited)

Side Effects

Erbisol is generally well tolerated. However, some patients may experience:

• Allergic reactions (rash, itching, or swelling)
• Gastrointestinal discomfort (nausea or abdominal pain)
• Headache or dizziness

Serious side effects are rare but may include anaphylaxis. Seek immediate medical attention if symptoms of a severe reaction appear.

Dosage and Administration

Typical dosage: 2 ml once or twice daily via intramuscular or subcutaneous injection. The course usually lasts 10–20 days, depending on indication.

Administration must be performed by a qualified healthcare provider. Do not self-inject unless trained and instructed to do so by a physician.

Overdose

No cases of overdose have been reported. In case of accidental overdose, symptomatic treatment is recommended.

Storage

Store at 2–8°C (in a refrigerator). Do not freeze. Keep out of reach of children. Use immediately after opening the vial.

Scientific References

• Erbisol as immunomodulator in chronic hepatitis therapy (PubMed)
• Clinical trials of Erbisol in hepatic and autoimmune conditions (elibrary.ru)

Disclaimer

This material is for informational purposes only and does not substitute professional medical advice. Always consult your healthcare provider before using any medication, including Erbisol.